Wolverine Trading’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$235K Sell
10,726
-24,462
-70% -$546K ﹤0.01% 4721
2025
Q2
$772K Buy
35,188
+18,788
+115% +$418K ﹤0.01% 2552
2025
Q1
$393K Buy
+16,400
New +$388K ﹤0.01% 3237
2021
Q3
Sell
-8,574
Closed -$438K 6878
2021
Q2
$565K Sell
8,574
-885
-9% -$48.1K ﹤0.01% 3514
2021
Q1
$413K Buy
+9,459
New +$351K ﹤0.01% 4007
2018
Q4
Sell
-11,477
Closed -$189K 5253
2018
Q3
$189K Buy
+11,477
New +$183K ﹤0.01% 4287

Other funds holding SGRY

Wolverine Trading's SGRY Position: Q3 2025 in Review

Wolverine Trading reduced its Surgery Partners (SGRY) stake by 70% in Q3 2025, selling an estimated $546K and leaving 10,726 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #4721.

Wolverine Trading first reported a position in SGRY in Q3 2018 and has held it in 6 quarters since. The position peaked at $772K in Q2 2025. 199 funds tracked by Wall St. Rank hold SGRY as of Q3 2025.

  • Wolverine Trading held 10,726 shares of Surgery Partners worth $235K as of Q3 2025.
  • Wolverine Trading sold 24,462 Surgery Partners shares in Q3 2025, an estimated $546K.
  • Surgery Partners made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4721 holding.
  • Wolverine Trading first reported a position in Surgery Partners in Q3 2018 and has held it in 6 quarters since.
  • Wolverine Trading's Surgery Partners position peaked at $772K in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.